AXXZIA Inc. (4936.T)
Shinjuku-ku, JP
AXXZIA Inc. manufactures and sells cosmetics and supplements in Japan. The company offers eyecare, skincare, supplements and drinks, salon care, hair care, hair styling, and beauty device products under the AXXZIA, AGtheory, LisBeau, LisBlanc, The B, Le Ciel de L'aube, Aither, NICE GLOW, Medullux, Venus Recipe, and RevWell brand names. It also provides products online. AXXZIA Inc. was incorporated in 2011 and is headquartered in Shinjuku, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.89% | +1.21% | +1.52% | -6.69% | -14.76% | -15.83% | -20.24% | -72.54% | -79.38% | -85.43% | -85.43% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+10.6% ★ Q2'26: -18.0% (vs Q2'25)
-
EPS growth Household & Personal Products: +8.8%-52.6% Q2'26: -96.6% (vs Q2'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+4.1% Q2'26: +0.0% (vs Q2'25)
-
EBIT margin Household & Personal Products: +9.9%+4.1% Q2'26: -1.1% (vs Q2'25)
-
ROIC Household & Personal Products: +8.2%+8.1% Q2'26: -2.0% (vs Q2'25)
-
Share dilution Household & Personal Products: +0.2%-6.0% ★ Q2'26: +0.0% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×1.15× ★ Q2'26: 15.01× (vs Q2'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jul 2021 actual |
Jul 2022 actual |
Jul 2023 actual |
Jul 2024 actual |
Jul 2025 actual |
Jul 2026 1 Rev. Ana. 1 EPS Ana. |
Jul 2027 1 Rev. Ana. 1 EPS Ana. |
Jul 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
5.79B
est: 5.62B (+3.0%)
|
8.22B
est: 7.70B (+6.7%)
|
11.34B
est: 10.98B (+3.3%)
|
12.19B
est: 12.19B (+0.0%)
|
13.48B
est: 13.50B (-0.1%)
|
13.55B
13.55B – 13.55B
+0.4% YoY
|
14.50B
14.50B – 14.50B
+7.0% YoY
|
15.50B
15.50B – 15.50B
+6.9% YoY
|
| EBITDA |
1.40B
est: 908.24M (+54.4%)
|
1.84B
est: 1.24B (+47.6%)
|
2.06B
est: 1.77B (+15.9%)
|
1.29B
est: 1.97B (-34.7%)
|
746.64M
est: 2.18B (-65.8%)
|
2.19B
2.19B – 2.19B
+0.4% YoY
|
2.34B
2.34B – 2.34B
+7.0% YoY
|
2.50B
2.50B – 2.50B
+6.9% YoY
|
| EBIT |
1.37B
est: 845.22M (+62.5%)
|
1.75B
est: 1.16B (+51.2%)
|
1.91B
est: 1.65B (+15.6%)
|
1.12B
est: 1.83B (-39.0%)
|
557.95M
est: 2.03B (-72.5%)
|
2.04B
2.04B – 2.04B
+0.4% YoY
|
2.18B
2.18B – 2.18B
+7.0% YoY
|
2.33B
2.33B – 2.33B
+6.9% YoY
|
| Net Income |
868.64M
est: 819.78M (+6.0%)
|
1.12B
est: 931.45M (+19.9%)
|
1.33B
est: 1.19B (+11.6%)
|
794.35M
est: 749.36M (+6.0%)
|
354.28M
est: 245.12M (+44.5%)
|
154.07M
154.07M – 154.07M
-37.1% YoY
|
203.10M
203.10M – 203.10M
+31.8% YoY
|
326.82M
326.82M – 326.82M
+60.9% YoY
|
| SGA |
2.67B
est: 3.39B (-21.2%)
|
4.52B
est: 4.64B (-2.6%)
|
6.91B
est: 6.61B (+4.5%)
|
8.51B
est: 7.35B (+15.9%)
|
9.36B
est: 8.14B (+15.1%)
|
8.17B
8.17B – 8.17B
+0.4% YoY
|
8.74B
8.74B – 8.74B
+7.0% YoY
|
9.34B
9.34B – 9.34B
+6.9% YoY
|
| EPS |
35.97
est: 35.12 (+2.4%)
|
43.28
est: 39.90 (+8.5%)
|
51.80
est: 51.10 (+1.4%)
|
32.06
est: 32.10 (-0.1%)
|
15.18
est: 10.50 (+44.6%)
|
6.60
6.60 – 6.60
-37.1% YoY
|
8.70
8.70 – 8.70
+31.8% YoY
|
14.00
14.00 – 14.00
+60.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-06-11 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-06-10 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-06-09 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-06-08 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-06-05 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-06-04 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-06-03 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-06-02 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-06-01 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-29 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-28 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-27 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-26 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-25 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-22 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-01 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Core TOPIX ETF 1475.T | 0.00% | 40.7K | 0.05% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Duan Zhuo | President & Representative Director | — | male |
| Jun Wu | MD & Head of Overseas Subsidiaries and Director | — | male |
| Shoi Oh | Executive Vice President of Marketing and Manufacturing & Director | — | male |
| Yasuhito Fukui | Director & GM of Management Department | — | — |
| Zhang Hui | Director and Domestic Sales and Planning Div Manager & GM of Overseas Sales Department | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4936.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
